Liquidity and DSRA at Q3 2026 end
Company: Core Scientific
The claim, verbatim
Liquidity and DSRA totaled $1,744.2 million in Q3 2026, down from $2,601.1 million in Q2 2026.
Source (primary)
Core Scientific Announces Third Quarter 2026 Results - Core Scientific (-, news_article)
View cached copy (2026-11-06)Live source ↗Archive.org ↗
Quote: “Liquidity and DSRA (3) $1,744.2 $2,601.1 $694.8”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific Announces Third Quarter 2026 Results - Core Scientific
Quote: “Liquidity and DSRA (3) $1,744.2 $2,601.1 $694.8”